These two studies did not evaluate BNP and high-sensitivity troponin levels, markers of left ventricular overload and myocardial injury, respectively, even though these markers are also prognostic markers in patients with cardiovascular disease. This evidence concerns the gene NPPB and cardiovascular disorder.